The EMA is to start a new review of the CV* risks associated with non-selective NSAIDs. Media release 14 January 2013 Pages: 3 - 3
The EMA's CHMP has clarified its opinion on pioglitazone and the associated risk of bladder cancer, Media release 14 January 2013 Pages: 3 - 3
Aspirin “neither safe nor effective” in atrial fibrillation Clinical study 14 January 2013 Pages: 4 - 4
Reassuring findings for ACE inhibitor use in first trimester Clinical study 14 January 2013 Pages: 4 - 4
More than a third (38%) of patients treated with clopidogrel [Plavix] are also receiving CYP2C19 inhibitors Media release 14 January 2013 Pages: 4 - 4
Medication causes 10% of lower urinary tract symptoms in men Clinical study 14 January 2013 Pages: 5 - 5
Complementary and alternative medicines/warfarin interaction Case report 14 January 2013 Pages: 12 - 12
